Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00223483 · ClinicalTrials.gov registry record
Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 512
- Enrollment target
NCT00223483 is a clinical trial that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 512 participants.
The verdict
NCT00223483 has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 512 participants
- Enrollment target
Study Summary
This research study goal is to analyze the plasma and the cells that make up part of the immune system. We want to learn how the plasma and cells work. These may influence why one person will develop an infection and another will not, or why one person develops severe symptoms of a disease while others remain without symptoms.
Interventions
- GENETIC Isolation of genomic DNA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2005-03 |
| Est. Completion | 2021-07-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00223483
The ClinicalTrials.gov registry entry for NCT00223483 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 512 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Isolation of genomic DNA is the first listed.
NCT00223483 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00223483 about?
NCT00223483 is a clinical study titled "Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers". This research study goal is to analyze the plasma and the cells that make up part of the immune system. We want to learn how the plasma and cells work. These may influence why one person will develop an infection and another will not, or why one person develops severe symptoms of a disease while oth...
What is the current status of trial NCT00223483?
This trial is currently completed. The enrollment target is 512 participants. The study started on 2005-03. Estimated completion is 2021-07-14.
What interventions are being tested in trial NCT00223483?
The interventions under investigation include: Isolation of genomic DNA (GENETIC).
Who is sponsoring clinical trial NCT00223483?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.